An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine
ME Pichichero, LM DeTora… - Expert Review of …, 2006 - Taylor & Francis
Pertussis causes substantial morbidity among adolescents and adults, as well as other
persons in contact with affected individuals. In the context of widespread childhood …
persons in contact with affected individuals. In the context of widespread childhood …
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) …
B Thierry-Carstensen, K Jordan, HH Uhlving, T Dalby… - Vaccine, 2012 - Elsevier
BACKGROUND: Increasing incidence of pertussis in adolescents and adults has stimulated
the development of safe and immunogenic acellular pertussis vaccines for booster …
the development of safe and immunogenic acellular pertussis vaccines for booster …
Acellular pertussis vaccines for adolescents
ME Pichichero, JR Casey - The Pediatric infectious disease …, 2005 - journals.lww.com
Background: The epidemiology of pertussis is changing, with a clear increase in the number
of cases diagnosed in adolescents and adults. This development has spurred studies and …
of cases diagnosed in adolescents and adults. This development has spurred studies and …
Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults
ME Pichichero, MB Rennels, KM Edwards, MM Blatter… - Jama, 2005 - jamanetwork.com
ContextIncreasing reports of pertussis among US adolescents, adults, and their infant
contacts have stimulated vaccine development for older age groups. ObjectiveTo assess the …
contacts have stimulated vaccine development for older age groups. ObjectiveTo assess the …
Prevention of pertussis across the age spectrum through the use of the combination vaccines PENTACEL™ and ADACEL™
SA Halperin - Expert Opinion on Biological Therapy, 2006 - Taylor & Francis
Acellular pertussis-containing combination vaccines are widely used in the developed world
for the control of pertussis and have been successful in controlling disease in preschool …
for the control of pertussis and have been successful in controlling disease in preschool …
An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults
SA Halperin, B Smith, M Russell, P Hasselback… - Vaccine, 2000 - Elsevier
Pertussis is increasingly being recognized as an important cause of cough illness in
adolescents and adults. To evaluate the safety and immunogenicity of an adult formulation …
adolescents and adults. To evaluate the safety and immunogenicity of an adult formulation …
Spotlight on Tdap5 Vaccine (Covaxis®) as a Single-Booster Immunization for the Prevention of Tetanus, Diphtheria, and Pertussis: In Children (Aged ≥4 Years) …
LJ Scott - Pediatric Drugs, 2011 - Springer
Covaxis®(also licensed as Triaxis® or Adacel® in individual countries) is a Tdap 5 (ie
combined tetanus toxoid, reduced diphtheria toxoid, five component acellular pertussis …
combined tetanus toxoid, reduced diphtheria toxoid, five component acellular pertussis …
Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four-to six-year-old children
ME Pichichero, KM Edwards, EL Anderson… - …, 2000 - publications.aap.org
Objective. To evaluate the safety and immunogenicity of 6 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) and with 1 licensed whole …
vaccines combined with diphtheria and tetanus toxoids (DTaP) and with 1 licensed whole …
Tdap5 Vaccine (Covaxis®) A Review of its Use as a Single-Booster Immunization for the Prevention of Tetanus, Diphtheria, and Pertussis in Children (Aged ≥4 …
LJ Scott - BioDrugs, 2010 - Springer
Covaxis®(also licensed as Triaxis® or Adacel® in individual countries) is a combined
tetanus toxoid, reduced diphtheria toxoid, five component acellular pertussis (namely …
tetanus toxoid, reduced diphtheria toxoid, five component acellular pertussis (namely …
A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15-to 20-month-old children
ME Pichichero, MA Deloria, MB Rennels… - …, 1997 - publications.aap.org
Objective. To compare the safety and immunogenicity of 12 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) with one licensed diphtheria …
vaccines combined with diphtheria and tetanus toxoids (DTaP) with one licensed diphtheria …